These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16002287)
61. Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents. Rochais C; Lisowski V; Dallemagne P; Rault S Bioorg Med Chem; 2006 Dec; 14(24):8162-75. PubMed ID: 17011196 [TBL] [Abstract][Full Text] [Related]
62. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands. Sasse BC; Mach UR; Leppaenen J; Calmels T; Stark H Bioorg Med Chem; 2007 Dec; 15(23):7258-73. PubMed ID: 17826096 [TBL] [Abstract][Full Text] [Related]
63. Synthesis and structure based optimization of novel Akt inhibitors. Lippa B; Pan G; Corbett M; Li C; Kauffman GS; Pandit J; Robinson S; Wei L; Kozina E; Marr ES; Borzillo G; Knauth E; Barbacci-Tobin EG; Vincent P; Troutman M; Baker D; Rajamohan F; Kakar S; Clark T; Morris J Bioorg Med Chem Lett; 2008 Jun; 18(11):3359-63. PubMed ID: 18456494 [TBL] [Abstract][Full Text] [Related]
64. 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modeling. Lager E; Andersson P; Nilsson J; Pettersson I; Nielsen EØ; Nielsen M; Sterner O; Liljefors T J Med Chem; 2006 Apr; 49(8):2526-33. PubMed ID: 16610795 [TBL] [Abstract][Full Text] [Related]
65. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors. David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851 [TBL] [Abstract][Full Text] [Related]
66. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807 [TBL] [Abstract][Full Text] [Related]
67. Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors. Leopoldo M; Lacivita E; Colabufo NA; Niso M; Berardi F; Perrone R Bioorg Med Chem; 2007 Aug; 15(15):5316-21. PubMed ID: 17517509 [TBL] [Abstract][Full Text] [Related]
68. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands. Lee M; Rangisetty JB; Pullagurla MR; Dukat M; Setola V; Roth BL; Glennon RA Bioorg Med Chem Lett; 2005 Mar; 15(6):1707-11. PubMed ID: 15745826 [TBL] [Abstract][Full Text] [Related]
69. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands. Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711 [TBL] [Abstract][Full Text] [Related]
70. Towards improving compound selection in structure-based virtual screening. Waszkowycz B Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797 [TBL] [Abstract][Full Text] [Related]
71. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists. Elokdah H; Li D; McFarlane G; Bernotas RC; Robichaud AJ; Magolda RL; Zhang GM; Smith D; Schechter LE Bioorg Med Chem; 2007 Sep; 15(18):6208-26. PubMed ID: 17624788 [TBL] [Abstract][Full Text] [Related]
72. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands. Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848 [TBL] [Abstract][Full Text] [Related]
73. N-arylsulfonyl-2-vinyltryptamines as new 5-HT6 serotonin receptor ligands. Raoul M; Patigny D; Fabis F; Dauphin F; Rault S; Sapi J; Laronze JY J Enzyme Inhib Med Chem; 2006 Jun; 21(3):251-60. PubMed ID: 16918072 [TBL] [Abstract][Full Text] [Related]